Propanc publishes recombinant proenzyme study in peer-reviewed journal

Go back to Propanc publishes recombinant proenzyme study in peer-reviewed journal
(NASDAQ: PPCB) Delayed: 0.64 +0.01 (1.59%)
Previous Close $0.63    52 Week High
Open $0.66    52 Week Low
Day High $0.67    P/E N/A 
Day Low $0.63    EPS
Volume 47,762